leadf
logo-loader
viewInnoCan Pharma

InnoCan Pharma unveils its new user-friendly commercial website

The site will allow consumers to browse smoothly through its premium CBD-infused derma cosmetic product collection

InnoCan Pharma - InnoCan Pharma unveils its new user-friendly commercial website
InnoCan Pharma founder CEO Iris Bincovich said this is a 'great opportunity for Innocan to start with B2C operations that will secure a new and sustainable source of income'

InnoCan Pharma Corporation (CSE:INNO) (OTCMKTS:INNPF) (FRA:IP4) on Tuesday unveiled its new user-friendly commercial web platform shop.innocanpharma.com. 

The company said that through its wholly-owned subsidiary, InnoCan Pharma Limited (InnoCan Israel), it has signed key agreements with top global companies for the fulfillment, logistics, and service of the website. 

The new website offers a user-friendly experience with excellent navigation and functionality, allowing consumers to see full product information.  The online product distribution will be handled by Brandzon Company Limited, a specialist in e-commerce growth and worldwide acceleration. The Brandzon team has a proven sales track record worldwide, with global third-party logistics (3PL) capabilities.

READ: Innocan Pharma's cosmetic clinical study indicates 90% wrinkle reduction in volunteers using SHIR Premium CBD Facial Serum

In a statement, Roni Kamhi, CEO and co-founder of Brandzon said: "InnoCan is a leading innovative pharmaceutical company that has the potential to bring an advanced formulated product into the skincare market with the science to back it.”

“Together we can achieve success in the e-commerce space and generate revenue for both companies."

In the meantime, InnoCan Pharma founder CEO Iris Bincovich said the company was “very pleased” to unveil its new website. 

"The site will allow consumers to browse smoothly through our product collection and find the perfect product that will meet their requirements,” added Bincovich.

“This is a major milestone and a great opportunity for Innocan to start with B2C operation that will secure a new and sustainable source of income for the company."

Innocan, through its wholly-owned Israeli subsidiary Innocan Pharma Ltd, is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol, or CBD.

The Israeli firm markets a line of premium CBD-infused derma cosmetic products, the SHIR Beauty & Science skincare brand that is distributed throughout the UK, Ireland and many other countries.

Contact the author Uttara Choudhury at uttara@proactiveinvestors.com

Follow her on Twitter: @UttaraProactive

Quick facts: InnoCan Pharma

Price: 0.37 CAD

CSE:INNO
Market: CSE
Market Cap: $65.01 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

K2fly welcomes new five-year SaaS deal with Coeur Mining

K2fly Ltd's (ASX:K2F) Nic Pollock caught up with Proactive's Andrew Scott following the news they've signed a five-year resource inventory management software as a service contract with New York Stock Exchange-listed precious metals mining company Coeur Mining Inc (NYSE:CDE) (FRA:CDM1). This...

8 hours, 3 minutes ago

2 min read